Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor

All categories
DBCAT003347Therapeutic category

A DrugBank category of 3 drugs. 3 of them are approved.

Drugs

What you can answer from here — as of October 25, 2017

3DrugsEach linked to its full drug card
Listed above
3Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,415Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
11Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In